Signifier Medical Technologies

Signifier Medical Technologies is a pioneer in the sleep apnea space with its FDA-authorized eXciteOSA device, a first-of-its-kind daytime neuromuscular stimulation therapy. The company targets the large and underserved market of mild OSA and primary snoring patients who are non-adherent to or intolerant of CPAP. Backed by clinical data showing reductions in snoring and apnea severity, and supported by a direct-to-consumer and physician-prescribed model, Signifier is commercializing a novel approach that treats a root cause of airway collapse. As a private company, it is scaling its commercial footprint in the US, UK, Germany, and Canada while continuing to build its clinical evidence base.

Daytime intra-oral neuromuscular electrical stimulation (NMES) platform to strengthen tongue muscles and reduce upper airway collapse during sleep.

Competes directly with CPAP (ResMed, Philips) and Mandibular Advancement Devices for mild OSA. Also competes with other anti-snoring devices and surgical options. Its primary differentiation is daytime use and a physiological restoration mechanism, rather than nighttime mechanical intervention.